BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 32102247)

  • 1. Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients.
    Paats J; Adoberg A; Arund J; Dhondt A; Fernström A; Fridolin I; Glorieux G; Leis L; Luman M; Gonzalez-Parra E; Perez-Gomez VM; Pilt K; Sanchez-Ospina D; Segelmark M; Uhlin F; Arduan Ortiz A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
    Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
    Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.
    Bataille S; Pelletier M; Sallée M; Berland Y; McKay N; Duval A; Gentile S; Mouelhi Y; Brunet P; Burtey S
    BMC Nephrol; 2017 Jul; 18(1):251. PubMed ID: 28747155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with Paracetamol Can Interfere with the Intradialytic Optical Estimation in Spent Dialysate of Uric Acid but Not of Indoxyl Sulfate.
    Adoberg A; Paats J; Arund J; Dhondt A; Fridolin I; Glorieux G; Holmar J; Lauri K; Leis L; Luman M; Pilt K; Uhlin F; Tanner R
    Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical Method and Biochemical Source for the Assessment of the Middle-Molecule Uremic Toxin β2-Microglobulin in Spent Dialysate.
    Paats J; Adoberg A; Arund J; Fridolin I; Lauri K; Leis L; Luman M; Tanner R
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
    Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S
    Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.
    Madero M; Cano KB; Campos I; Tao X; Maheshwari V; Brown J; Cornejo B; Handelman G; Thijssen S; Kotanko P
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):394-402. PubMed ID: 30755453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over Time.
    Krieter DH; Kerwagen S; Rüth M; Lemke HD; Wanner C
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30654454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-bound uraemic toxins, dicarbonyl stress and advanced glycation end products in conventional and extended haemodialysis and haemodiafiltration.
    Cornelis T; Eloot S; Vanholder R; Glorieux G; van der Sande FM; Scheijen JL; Leunissen KM; Kooman JP; Schalkwijk CG
    Nephrol Dial Transplant; 2015 Aug; 30(8):1395-402. PubMed ID: 25862762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-volume hemodiafiltration decreases the pre-dialysis concentrations of indoxyl sulfate and p-cresyl sulfate compared to hemodialysis: a post-hoc analysis from the HDFit randomized controlled trial.
    Lima JD; Guedes M; Rodrigues SD; Flórido ACS; Moreno-Amaral AN; Barra AB; Canziani ME; Cuvello-Neto A; Poli-de-Figueiredo CE; Pecoits-Filho R; Nakao LS
    J Nephrol; 2022 Jun; 35(5):1449-1456. PubMed ID: 35239175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of Urea, β2-Microglobulin, and Indoxyl Sulfate Assessed by Absorbance and Fluorescence in the Spent Dialysate During Hemodialysis.
    Lauri K; Arund J; Holmar J; Tanner R; Kalle S; Luman M; Fridolin I
    ASAIO J; 2020 Jun; 66(6):698-705. PubMed ID: 31425267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities.
    Meert N; Eloot S; Schepers E; Lemke HD; Dhondt A; Glorieux G; Van Landschoot M; Waterloos MA; Vanholder R
    Nephrol Dial Transplant; 2011 Aug; 26(8):2624-30. PubMed ID: 21310741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.
    Blankestijn PJ; Fischer KI; Barth C; Cromm K; Canaud B; Davenport A; Grobbee DE; Hegbrant J; Roes KC; Rose M; Strippoli GF; Vernooij RW; Woodward M; de Wit GA; Bots ML
    BMJ Open; 2020 Feb; 10(2):e033228. PubMed ID: 32029487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Fluorescence Valid to Monitor Removal of Protein Bound Uremic Solutes in Dialysis?
    Arund J; Luman M; Uhlin F; Tanner R; Fridolin I
    PLoS One; 2016; 11(5):e0156541. PubMed ID: 27228162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
    Shi Y; Wang Y; Ma S; Liu T; Tian H; Zhu Q; Wang W; Li Y; Ding F
    Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis.
    Schiffl H
    Eur J Med Res; 2007 Jan; 12(1):26-33. PubMed ID: 17363355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease.
    Liabeuf S; Laville SM; Glorieux G; Cheddani L; Brazier F; Titeca Beauport D; Valholder R; Choukroun G; Massy ZA
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients?
    Eloot S; Van Biesen W; Glorieux G; Neirynck N; Dhondt A; Vanholder R
    PLoS One; 2013; 8(11):e76838. PubMed ID: 24236005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Dialysis Removal of Protein-Bound Uraemic Toxins with a Combined Displacement and Adsorption Technique.
    Shi Y; Tian H; Wang Y; Shen Y; Zhu Q; Ding F
    Blood Purif; 2022; 51(6):548-558. PubMed ID: 34515053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.